Last reviewed · How we verify
NCT04875156
The Angle of the Metacarpophalangeal Joint of the Thumb During Maximal Pinch Strength
NA trial testing measurement of range of motion and strength in Post-traumatic; Arthrosis in 300 participants. Completed in 17 April 2021.
17 April 2021
Quick facts
| Lead sponsor | University Hospital, Ghent |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 23 September 2020 |
| Primary completion | 17 April 2021 |
| Estimated completion | 17 April 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- measurement of range of motion and strength
Conditions studied
- Post-traumatic; Arthrosis — all drugs for Post-traumatic; Arthrosis →
- Osteoarthritis Thumb — all drugs for Osteoarthritis Thumb →
Sponsor
University Hospital, Ghent
Who can join
Adults 18 to 40, any sex, with Post-traumatic; Arthrosis or Osteoarthritis Thumb. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to measure the position of the metacarpophalangeal joint of the thumb during key-pinch, tripod-pinch and opposition-pinch in normal volunteers, to determine the optimal position of metacarpophalangeal joint arthrodesis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04875156
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-traumatic; Arthrosis
Currently open trials in the same condition.
- NCT04731077 — Avenir Complete Post-Market Clinical Follow-Up Study · NA · active not recruiting
- NCT03226808 — Vivacit-E Post-market Follow-up Study · NA · active not recruiting
Other University Hospital, Ghent trials
Trials by the same sponsor.
- NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
- NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
- NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04875156 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
- Last refreshed: 6 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04875156.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing